首页> 中文期刊>临床麻醉学杂志 >组胺受体1和2拮抗药对神经病理性疼痛的疗效

组胺受体1和2拮抗药对神经病理性疼痛的疗效

     

摘要

Objective To investigate the efficiency of intracerebroventricular injection of histamine receptor antagonists on mechanical pain threshold of neuropathic pain in rats. Methods The neuropathic pain rat model was established by partially ligation of the sciatic nerve in 30 rats. Two weeks later, histamine receptor 1 antagonist pyrilamine 1.5 μg or 15 μg was injected intracerebroventricularly in group P1 or P2, histamine receptor 2 antagonist ranitidine 10 μg or 100 μg in group R1 or R2, and normal saline in group C as the control. The pain threshold was measured. Results Compaered with group C,the pain threshold was signifigantly increased in group R1 and R2, especially in group R2 (P<0.05). Conclusion Histamine H2 receptor antagonist can increase pain threshold in rats with neuropathic pain.%目的 探讨脑室内注射组胺受体拮抗药对神经病理性疼痛大鼠的治疗作用.方法 选择左侧坐骨神经部分结扎致神经病理性疼痛大鼠30只,随机均分为五组.对照组(C组)脑室内注射生理盐水;P1、P2组分别注射组胺受体1拮抗药美吡拉敏1.5 μg和15 μg;R1、R2组注射组胺受体2拮抗药雷尼替丁10μ和100 μg,评价注药后痛阈的改变.结果 与C组相比,R1、R2组雷尼替丁能显著提高大鼠对机械性刺激的痛阈(P<0.05);且R2组对疼痛的治疗效果加强,时间延长.结论 神经病理性疼痛时,采用组胺受体2拮抗药能提高痛阈,缓解疼痛.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号